In our July event, we will address:
- How tech entrepreneurs should prepare their companies for acquisition.
- How to clearly identify your exit goals and be aligned with those positioning your company for sale.
- The many resources available to help you along the way.
Sonali is an entrepreneur, investor, mentor, technologist, curious traveler, and a mom. She is the Founder and Managing Partner of Augment Ventures. Her company invests in early stage technology companies creating Enterprise software and smart hardware that will impact efficiency, sustainability, and health and wellness. Recent successes include AI-based supply chain software company, Llamasoft that was sold for $1.5 billion. Over the last 25 years, Sonali has worked with entrepreneurs and mentored teams to turn new ideas into reality. Prior to starting her VC career, she worked in India with PwC and Edelweiss, taking companies to NASDAQ and Bombay Stock Exchange.
Frank is part of Bodman’s business and banking practice groups. He focuses his practice on M&A, debt finance and mid- and later-stage venture financings, with an emphasis on middle market sale transactions, assisting companies negotiate exits with strategic and financial buyers. He also represents numerous ultra-high net worth individuals and their family offices in their alternative investment transactions, including private equity, private funds and direct VC investments. In the venture space, Frank has worked on deals ranging from small Ann Arbor startups doing their first seed rounds to pre-IPO financings for large unicorn companies, including Uber and other household names. He has done numerous company exits, generally in the middle-market. He also represents several Michigan venture funds and the venture arm of one of Michigan’s F500 companies in their VC transactions.
Tim Petersen is a managing partner at Arboretum Ventures, a healthcare venture capital firm that he co-founded in 2002. Tim focuses on transformative opportunities that disrupt healthcare sectors starved of technology or business model innovation. Examples of Tim’s successful companies include Inogen, which revolutionized the delivery of oxygen to COPD patients, and Pear Therapeutics, developer of the country’s first FDA cleared “prescription digital therapeutic.” Other public and exited investments include SI-Bone and behavioral health technology company HealthMedia, sold to Johnson & Johnson. Before co-founding Arboretum, Tim helped establish the Zell Lurie Institute (ZLI) for Entrepreneurial Studies at the University of Michigan, serving as its managing director. He also directed the activities of the Wolverine Venture Fund, which invests in early-stage life science and technology investments.